University of Miami Sylvester Comprehensive Cancer Center


 

TGF Beta Pathway Inhibition in MDS: Luspatercept Significantly Decreases Transfusion Dependence in RARS MDS and Stimulates Late Stage of Erythroid Differentiation

115 views
May 14, 2020
Comments 0
Login to view comments. Click here to Login